Flow cytometric analysis of cerebrospinal fluid showed the presence of CD19+/CD20+ aberrant B-cells with kappa light chain restriction in 9.3% of all cells confirming CNS relapse of mantle cell lymphoma, clinically with progressive motoric weakness in both legs. This evidence concerns the gene CD19 and mantle cell lymphoma.